Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.86 USD | +16.27% | -18.74% | +229.91% |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 38.42 | 19.82 | 84.29 | - |
Enterprise Value (EV) 1 | 38.42 | 19.82 | 84.29 | 84.29 |
P/E ratio | -2.01 x | -0.79 x | -2.44 x | - |
Yield | - | - | - | - |
Capitalization / Revenue | - | - | - | 3.4 x |
EV / Revenue | - | - | - | 3.4 x |
EV / EBITDA | -2.38 x | -0.98 x | -2.86 x | -2.52 x |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 10,946 | 16,944 | 21,837 | - |
Reference price 2 | 3.510 | 1.170 | 3.860 | 3.860 |
Announcement Date | 3/24/23 | 3/21/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | - | - | - | - | 24.77 |
EBITDA 1 | - | -16.18 | -20.18 | -29.48 | -33.39 |
EBIT 1 | - | -16.18 | -20.18 | -33.48 | -34.54 |
Operating Margin | - | - | - | - | -139.45% |
Earnings before Tax (EBT) 1 | - | -15.77 | -19.77 | -33.49 | -34.55 |
Net income 1 | -12.5 | -16.22 | -19.77 | -33.49 | -34.55 |
Net margin | - | - | - | - | -139.49% |
EPS 2 | -2.370 | -1.750 | -1.490 | -1.585 | - |
Free Cash Flow | - | - | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 4/11/22 | 3/24/23 | 3/21/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - |
EBIT | - | -5.294 | -4.184 | -4.665 | -4.956 | -6.378 | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | -5.117 | -4.117 | -4.524 | -4.876 | -6.257 | - | - | - | - |
Net income | - | -5.568 | -4.117 | -4.524 | -4.876 | -6.257 | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.4800 | -0.3500 | -0.3800 | -0.3500 | -0.3600 | -0.4100 | -0.4600 | -0.4150 | -0.3950 | -0.5000 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 2/6/23 | 3/24/23 | 5/8/23 | 8/8/23 | 11/7/23 | 3/21/24 | 5/14/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 4/11/22 | 3/24/23 | 3/21/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+229.91% | 84.29M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- MAIA Stock
- Financials MAIA Biotechnology, Inc.